March 14, 2014
Forest Laboratories Inc. was hit with a proposed class action in Massachusetts federal court Thursday by two funds that say the company deceptively and unlawfully marketed adolescent depression drugs Celexa and Lexapro by using misleading drug labels and paying people to endorse them.